Table 3.
PERI-OPERATIVE ANALGESIC MEDICATIONS ADMINISTERED
| Latino | Caucasian | p-value (unstratified) | p-value (stratifieda) | |
|---|---|---|---|---|
| Non-opioid analgesics N (%) | .81 | NA | ||
| Acetaminophen | 10 (21%) | 13 (28%) | ||
| Ketorolac ± acetaminophen | 1 (2%) | 1 (92%) | ||
| None | 36 (77%) | 33 (70%) | ||
| Intraoperative opioid analgesics morphine equivalents/kg median (range) | 0.06 (0–0.14) | 0.07 (0–0.65) | .26 | NA |
| Type of intraoperative opioid analgesic used N (%) | .01 | NA | ||
| None | 1 (2%) | 4 (9%) | ||
| Long acting (morphine) | 20 (43%) | 30 (64%) | ||
| Short acting (alfentanil/fentanyl) | 26 (55%) | 13 (28%) | ||
| Phase I opioid analgesics morphine equivalents/kg median (range) | 0.05 (0–0.14) | 0.07 (0–0.90) | .04 | .02 |
| Phase II opioid analgesics morphine equivalents/kg median (range) | 0 (0–0.07) | 0 (0–0.08) | .24 | .16 |
a
Mann-Whitney rank-sum test conducted with stratification for type of opioid use intraoperatively. The strata were: none, long acting (morphine) and short acting (fentanyl and alfentanyl).